Clinical Trial Update: Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating daratumumab in multiple myeloma patients who are >VGPR/MRD-positive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Senese | Conditions: Myeloma Multiple | Phase 2 | Status: UNKNOWN